Nebulette Inhibitors
Nebulette inhibitors, as a class, are not well-defined due to the absence of direct chemical inhibitors targeting Nebulette. However, the inhibition of Nebulette's function could conceptually be achieved by targeting various signaling pathways and cellular processes that indirectly impact Nebulette's role within the sarcomere of muscle cells. Since Nebulette is associated with actin filaments within the muscle cell, compounds that affect actin dynamics, actin-associated protein kinases, or signaling pathways that regulate actin filament formation and function can alter the physiological role of Nebulette.
For example, blebbistatin, by inhibiting myosin II, disrupts the actomyosin interactions crucial for muscle contraction and sarcomere integrity. Since Nebulette is instrumental in maintaining sarcomere structure, altering myosin function can indirectly affect Nebulette's stability and function. Similarly, compounds such as Staurosporine or Y-27632 can influence kinase pathways that indirectly affect the actin cytoskeleton and its associated proteins. By modifying these signaling cascades, the functional context in which Nebulette operates within the cell can be altered.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can affect various signaling pathways, possibly altering the phosphorylation state of proteins that interact with Nebulette. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
A myosin II inhibitor which could disrupt myosin-actin interactions and thereby affect the sarcomere organization where Nebulette is localized. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can modify downstream signaling, potentially affecting the actin cytoskeleton and its associated proteins, including Nebulette. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that could have a similar effect to Wortmannin, altering signaling pathways relevant to Nebulette's function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, which may influence actin dynamics and indirectly affect the structural proteins in the sarcomere, including Nebulette. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
An inhibitor of myosin light chain kinase (MLCK), which could impact the contraction of the sarcomere and potentially the function of Nebulette within it. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
An Arp2/3 complex inhibitor that can disrupt actin polymerization, possibly affecting the actin network that interacts with Nebulette. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
A broad-spectrum matrix metalloproteinase inhibitor that may alter the extracellular matrix, potentially influencing the mechanical environment of Nebulette. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which may alter the ERK/MAPK signaling pathway, potentially influencing protein interactions with Nebulette. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that could modify cytoskeletal dynamics, indirectly affecting Nebulette's role in the sarcomere. | ||||||